Moonlake Immunotherapeutics Stock Return On Asset
| MLTX Stock | USD 39.75 1.11 2.72% |
MoonLake Immunotherapeutics fundamentals help investors to digest information that contributes to MoonLake Immunotherapeuti's financial success or failures. It also enables traders to predict the movement of MoonLake Stock. The fundamental analysis module provides a way to measure MoonLake Immunotherapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MoonLake Immunotherapeuti stock.
Return On Assets is likely to drop to -0.07 in 2024. MoonLake | Return On Asset |
MoonLake Immunotherapeutics Company Return On Asset Analysis
MoonLake Immunotherapeuti's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MoonLake Immunotherapeuti Return On Asset | -0.12 |
Most of MoonLake Immunotherapeuti's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MoonLake Immunotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MoonLake Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for MoonLake Immunotherapeuti is extremely important. It helps to project a fair market value of MoonLake Stock properly, considering its historical fundamentals such as Return On Asset. Since MoonLake Immunotherapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MoonLake Immunotherapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MoonLake Immunotherapeuti's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
MoonLake Total Assets
Total Assets |
|
Based on the latest financial disclosure, MoonLake Immunotherapeutics has a Return On Asset of -0.1209. This is 98.62% lower than that of the Biotechnology sector and 99.49% lower than that of the Health Care industry. The return on asset for all United States stocks is 13.64% lower than that of the firm.
MoonLake Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MoonLake Immunotherapeuti's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MoonLake Immunotherapeuti could also be used in its relative valuation, which is a method of valuing MoonLake Immunotherapeuti by comparing valuation metrics of similar companies.MoonLake Immunotherapeuti is currently under evaluation in return on asset category among related companies.
MoonLake Immunotherapeuti ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MoonLake Immunotherapeuti's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MoonLake Immunotherapeuti's managers, analysts, and investors.Environmental | Governance | Social |
MoonLake Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.12 | ||||
| Current Valuation | 1.97 B | ||||
| Shares Outstanding | 62.87 M | ||||
| Shares Owned By Insiders | 15.27 % | ||||
| Shares Owned By Institutions | 97.10 % | ||||
| Number Of Shares Shorted | 6.93 M | ||||
| Price To Book | 5.56 X | ||||
| EBITDA | (54.11 M) | ||||
| Net Income | (36.01 M) | ||||
| Cash And Equivalents | 92.71 M | ||||
| Cash Per Share | 2.51 X | ||||
| Total Debt | 3.7 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 25.51 X | ||||
| Book Value Per Share | 8.63 X | ||||
| Cash Flow From Operations | (42.78 M) | ||||
| Short Ratio | 19.60 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 70.93 | ||||
| Number Of Employees | 50 | ||||
| Beta | 1.19 | ||||
| Market Capitalization | 2.5 B | ||||
| Total Asset | 526.54 M | ||||
| Retained Earnings | (116.66 M) | ||||
| Working Capital | 504.2 M | ||||
| Net Asset | 526.54 M |
About MoonLake Immunotherapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MoonLake Immunotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MoonLake Immunotherapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MoonLake Immunotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MoonLake Immunotherapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MoonLake Immunotherapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moonlake Immunotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moonlake Immunotherapeutics Stock:Check out MoonLake Immunotherapeuti Piotroski F Score and MoonLake Immunotherapeuti Altman Z Score analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for MoonLake Stock analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is MoonLake Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MoonLake Immunotherapeuti. If investors know MoonLake will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MoonLake Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Return On Assets (0.12) | Return On Equity (0.15) |
The market value of MoonLake Immunotherapeuti is measured differently than its book value, which is the value of MoonLake that is recorded on the company's balance sheet. Investors also form their own opinion of MoonLake Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is MoonLake Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MoonLake Immunotherapeuti's market value can be influenced by many factors that don't directly affect MoonLake Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MoonLake Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if MoonLake Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MoonLake Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.